Valuation : Teva Pharmaceutical Industries Limited

Market Cap 42.17B 36.4B 34.28B 31.28B 58.39B 4,005B 58.83B 406B 157B 2,037B 158B 155B 6,694B P/E 2026 *
48.6x
P/E 2027 * 19.9x
Enterprise Value 54.07B 46.67B 43.96B 40.11B 74.87B 5,135B 75.43B 520B 202B 2,612B 203B 199B 8,583B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 2.94x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -

Last Transcript : Teva Pharmaceutical Industries Limited

1 day+3.59%
1 week-1.60%
Current month+3.99%
1 month+7.08%
3 months+8.23%
6 months+10.72%
Current year+20.12%
1 week 35.62
Extreme 35.62
38.37
1 month 33.78
Extreme 33.7804
38.37
Current year 27.93
Extreme 27.93
38.37
1 year 18.21
Extreme 18.21
38.37
3 years 8.06
Extreme 8.055
38.37
5 years 6.78
Extreme 6.7791
38.37
10 years 6.07
Extreme 6.07
52.66
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2022
Director of Finance/CFO 53 21/12/2019
Chief Operating Officer 52 02/06/2024
Director TitleAgeSince
Director/Board Member 69 31/12/2008
Chairman 78 05/02/2017
Director/Board Member 65 31/08/2015
Date Insider Type Main position Quantity % Market Cap. Importance
21/08/26 Sell

Controller/Auditor

-14,445 0.0012%
21/08/26 Sell

Director

-415 0.0000%
17/08/26 Sell

EVP, Business Development

-18,600 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+3.59%-1.60%+103.97%+281.00% 42.17B
+0.01%-5.96%+58.36%+108.23% 1,034B
+1.48%+0.76%+55.34%+71.49% 654B
+0.67%-1.53%+24.39%+76.60% 459B
+0.49%-6.58%+34.20%+34.59% 343B
+0.27%+2.32%+29.33%+46.97% 307B
+0.12%-4.01%+1.06%+11.93% 251B
+1.08%+0.14%+53.92%+72.51% 237B
+2.64%-2.00%-17.38%-53.64% 202B
-0.21%+0.56%+32.43%+95.19% 186B
Average +0.98%-3.09%+37.56%+74.49% 371.38B
Weighted average by Cap. +0.65%-3.33%+39.95%+69.74%

Financials

2026 *2027 *
Net sales 16.59B 14.32B 13.49B 12.31B 22.97B 1,575B 23.14B 160B 61.93B 801B 62.3B 60.94B 2,633B 17.3B 14.94B 14.07B 12.84B 23.96B 1,643B 24.14B 167B 64.6B 836B 64.98B 63.56B 2,747B
Net income 1.44B 1.24B 1.17B 1.07B 2B 137B 2.01B 13.87B 5.38B 69.61B 5.41B 5.29B 229B 2.69B 2.32B 2.19B 1.99B 3.72B 255B 3.75B 25.87B 10.04B 130B 10.09B 9.87B 427B
Net Debt 11.9B 10.27B 9.68B 8.83B 16.48B 1,130B 16.6B 115B 44.43B 575B 44.69B 43.72B 1,889B 8.65B 7.47B 7.03B 6.42B 11.98B 822B 12.07B 83.25B 32.3B 418B 32.49B 31.78B 1,373B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
02/09/26 US$37.49 +3.59% 7,660,247
01/09/26 US$36.19 +0.39% 3,515,716
31/08/26 US$36.05 -1.07% 5,778,765
28/08/26 US$36.44 -3.14% 3,140,917
27/08/26 US$37.62 -0.79% 4,721,594
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
37.49USD
Average target price
41.40USD
Spread / Average Target
+10.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TEVA Stock